CoChat
Sign Up
Cited by 170Pancreatic and Hepatic Oncology ResearchNeuroendocrine Tumor Research AdvancesPancreatitis Pathology and Treatment

Multicenter study of serous cystic neoplasm of the Japan pancreas society

Kimura, Wataru, Moriya, Toshiyuki, Hanada, Keiji, Abe, Hideki, Yanagisawa, Akio, Fukushima, Noriyoshi, Ohike, Nobuyuki, Shimizu, Michio +10 more·2012·Pancreas
DOI 10.1097/mpa.0b013e31822a27db
Open this paper in CoChat — free account

Abstract

OBJECTIVES: There have been only a few reports on follow-up results of serous cystic neoplasm (SCN) of the pancreas. The frequency of malignancy and surgical indication of SCN are not determined yet. METHODS: In this multi-institutional study of the Japan Pancreas Society, a total of 172 patients with SCN were enrolled. The mean follow-up period was 4.5 years. Surgical resection was performed in 90 patients, whereas the remaining 82 were simply observed. RESULTS: Of all patients, 20% were symptomatic. The tumor was located in the pancreatic head (39%), body (35%), and tail (22%). The mean diameter of the tumor was 4.1 cm. None of the patients showed distant or lymph node metastasis except for liver metastasis found in 2 patients (1.2%). No patient died during the follow-up. The preoperative diagnosis did not correctly identify SCN in 57 (63%) of 90 resected cases. A honeycomb appearance, which is one of the most characteristic findings of SCN, could be diagnosed better by endoscopic ultrasonography than by other imaging diagnostic modalities. CONCLUSIONS: Surgical resection should be considered only when clear distinction from other surgical diseases is difficult, when symptoms or mass effects are present, and when the tumor size is large.

Integrity signals

Registry

Crossref · 10.1097/mpa.0b013e31822a27db

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High-risk groups for pancreatic ductal adenocarcinoma include people with inherited predisposition, people with pancreatic cystic lesions, and people older than 50 years with newly diagnosed type 2 diabetes.

    “Here, we review groups at high risk for pancreatic ductal adenocarcinoma, including individuals with inherited predisposition and patients with pancreatic cystic lesions.”

    From Early detection of pancreatic cancer (2020) · cites this paper as [19]

  • The 5% lifetime-risk target group includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes, and individuals with mucinous cystic lesions of the pancreas.

    “This target includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes (eg, Peutz-Jeghers syndrome, or germline mutations in the CDKN2A, BRCA2, or PALB2),6,54 and individuals with mucinous cystic lesions of the pancreas.19–21”

    From Early detection of pancreatic cancer (2020) · cites this paper as [19]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Kimura, W., Moriya, T., Hanada, K., Abe, H., Yanagisawa, A., Fukushima, N., Ohike, N., Shimizu, M., Hatori, T., Fujita, N., Maguchi, H., Shimizu, Y., Yamao, K., Sasaki, T., Naito, Y., Tanno, S., Tobita, K., & Tanaka, M.
Affiliations
  • Yamagata University (JP)
  • Tokai University (JP)
  • Kyushu University (JP)
  • Kyoto Prefectural University of Medicine (JP)
  • Jichi Medical University (JP)
  • Hiroshima University (JP)
  • Kurume University (JP)
Corresponding author
  • Kimura, Wataru
  • Moriya, Toshiyuki
  • Hatori, Takashi
  • Tanno, Satoshi
ORCID
Venue
Pancreas
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2012-04
Volume
41
Issue
3
Pages
380-387
ISSN
0885-3177 (ISSN-L)
DOI
10.1097/mpa.0b013e31822a27db
OpenAlex
W2027449707
Cited by
170
References
35
Citations by year
2026: 8 · 2025: 8 · 2024: 8 · 2023: 13 · 2022: 12 · 2021: 6 · 2020: 10 · 2019: 13 · 2018: 13 · 2017: 14 · 2016: 16 · 2015: 18 · 2014: 13 · 2013: 13 · 2012: 3
FWCI
7.44
Type
journal article
Language
en
Open access
closed
Locations
  • Pancreas (publishedVersion)
  • PubMed (publishedVersion)
Funders
Johns Hopkins University
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
Keywords
serous cystic neoplasm, pancreatic cysts, pancreatic cancer, malignancy rate, surgical resection, endoscopic ultrasound, honeycomb appearance, liver metastasis, preoperative diagnosis, tumor size, surgical indications
MeSH terms
Adult, Aged, Aged, 80 and over, Diagnosis, Differential, Diagnostic Imaging, Female, Humans, Japan, Liver Neoplasms, Male, Middle Aged, Pancreatectomy, Pancreatic Neoplasms, Predictive Value of Tests, Splenectomy, Time Factors, Pancreaticoduodenectomy, Treatment Outcome, Cystadenoma, Mucinous, Cystadenoma, Serous, Tumor Burden, Young Adult, Watchful Waiting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review